» Articles » PMID: 16982824

Lack of in Vitro and in Vivo Recognition of Francisella Tularensis Subspecies Lipopolysaccharide by Toll-like Receptors

Abstract

Francisella tularensis is an intracellular gram-negative bacterium that is highly infectious and potentially lethal. Several subspecies exist of varying pathogenicity. Infection by only a few organisms is sufficient to cause disease depending on the model system. Lipopolysaccharide (LPS) of gram-negative bacteria is generally recognized by Toll-like receptor 4 (TLR4)/MD-2 and induces a strong proinflammatory response. Examination of human clinical F. tularensis isolates revealed that human virulent type A and type B strains produced lipid A of similar structure to the nonhuman model pathogen of mice, Francisella novicida. F. novicida LPS or lipid A is neither stimulatory nor an antagonist for human and murine cells through TLR4 or TLR2. It does not appear to interact with TLR4 or MD-2, as it is not an antagonist to other stimulatory LPS. Consistent with these observations, aerosolization of F. novicida LPS or whole bacteria induced no inflammatory response in mice. These results suggest that poor innate recognition of F. tularensis allows the bacterium to evade early recognition by the host innate immune system to promote its pathogenesis for mammals.

Citing Articles

Tick-Borne Bacterial Diseases in Europe: Threats to public health.

Pustijanac E, Bursic M, Millotti G, Paliaga P, Ivesa N, Cvek M Eur J Clin Microbiol Infect Dis. 2024; 43(7):1261-1295.

PMID: 38676855 DOI: 10.1007/s10096-024-04836-5.


Glycerol monolaurate inhibits growth and is produced intracellularly in an ISG15-dependent manner.

Upton E, Schlievert P, Zhang Y, Rauckhorst A, Taylor E, Radoshevich L MicroPubl Biol. 2023; 2023.

PMID: 37954520 PMC: 10638595. DOI: 10.17912/micropub.biology.000905.


Pathogenicity and virulence of .

Degabriel M, Valeva S, Boisset S, Henry T Virulence. 2023; 14(1):2274638.

PMID: 37941380 PMC: 10653695. DOI: 10.1080/21505594.2023.2274638.


Lipidomics Characterization of the Microbiome in People with Diabetic Foot Infection Using MALDI-TOF MS.

Walczak-Skierska J, Monedeiro F, Maslak E, Zloch M Anal Chem. 2023; 95(44):16251-16262.

PMID: 37877781 PMC: 10633811. DOI: 10.1021/acs.analchem.3c03071.


disrupts TLR2-MYD88-p38 signaling early during infection to delay apoptosis of macrophages and promote virulence in the host.

Benziger P, Kopping E, McLAUGHLIN P, Thanassi D mBio. 2023; 14(4):e0113623.

PMID: 37404047 PMC: 10470500. DOI: 10.1128/mbio.01136-23.


References
1.
Saitoh S, Akashi S, Yamada T, Tanimura N, Kobayashi M, Konno K . Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. Int Immunol. 2004; 16(7):961-9. DOI: 10.1093/intimm/dxh097. View

2.
Somerville Jr J, Cassiano L, Bainbridge B, Cunningham M, Darveau R . A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J Clin Invest. 1996; 97(2):359-65. PMC: 507025. DOI: 10.1172/JCI118423. View

3.
Brandenburg K, Wiese A . Endotoxins: relationships between structure, function, and activity. Curr Top Med Chem. 2004; 4(11):1127-46. DOI: 10.2174/1568026043388213. View

4.
Johansson A, Farlow J, Larsson P, Dukerich M, Chambers E, Bystrom M . Worldwide genetic relationships among Francisella tularensis isolates determined by multiple-locus variable-number tandem repeat analysis. J Bacteriol. 2004; 186(17):5808-18. PMC: 516809. DOI: 10.1128/JB.186.17.5808-5818.2004. View

5.
Phillips N, Schilling B, McLendon M, Apicella M, Gibson B . Novel modification of lipid A of Francisella tularensis. Infect Immun. 2004; 72(9):5340-8. PMC: 517411. DOI: 10.1128/IAI.72.9.5340-5348.2004. View